www.washingtontimes.com

www.washingtontimes.com
Share

www.washingtontimes.com

 •  January 12

COLUMBUS, Ohio (AP) - The Latest on consolidated lawsuits against drugmakers over the opioid epidemic (all times local): 5:15 p.m. A federal judge who’s overseeing lawsuits from around the country against the pharmaceutical industry has invited state attorneys general to participate in the case. Judge Dan Polster in Cleveland is overseeing a...

www.washingtontimes.com

 •  January 11

President Trump’s pick to run the Department of Health and Human Services vowed Tuesday to work with Congress to cut prescription drug prices — and said his own history as a pharmaceutical executive doesn’t taint him. But Alex M. Azar, a former executive at Eli Lilly, said he’s wary of having the federal government negotiate prices directly with...

www.washingtontimes.com

 •  December 20, 2017

ANALYSIS/OPINION: The U.S. Department of Health and Human Services just proposed a rule that could dramatically lower seniors’ out-of-pocket drug spending. Lobbyists for the nation’s largest pharmacy benefits managers (PBM) are sure to fight the proposal tooth and nail. These PBMs, which effectively set drug prices for the entire country, want to...

www.washingtontimes.com

 •  October 26, 2017

COLUMBUS, Ohio (AP) - Backers of a fall ballot issue in Ohio aimed at lowering what the state pays for drugs have been outspent by the pharmaceutical industry-funded opposition by nearly 4-1. Campaign finance reports filed Thursday show Ohioans Against the Deceptive Rx Ballot Issue has spent $39.4 million against Issue 2 since July. It still has...

www.washingtontimes.com

 •  September 8, 2017

ANALYSIS/OPINION: September is National Recovery Month. We are facing a drug abuse death epidemic in America. Over 50,000 a year die from overdoses, 144 a day. President recently Trump recently declared it an “emergency.” The Centers for Disease Control and Prevention (CDC) reported that over 33,000 persons last year died from opioid overdoses....

www.washingtontimes.com

 •  August 22, 2017

They lost in California, but that hasn’t stopped activists from waging a referendum war in Ohio against the big pharmaceutical companies. If approved by voters in November, Ohio agencies and state-assisted programs would be required to buy prescription drugs at prices no higher than what the U.S. Department of Veterans Affairs pays for them —...

www.washingtontimes.com

 •  May 31, 2017

Enthusiasm for a new medication to treat multiple sclerosis was tempered this week by news that a patient in Germany contracted a potentially deadly brain infection after switching to the drug Ocrevus. The German patient contracted progressive multifocal leukoencephalopathy (PML) after switching from the MS medication Tysabri to Ocrevus in April,...

www.washingtontimes.com

 •  February 14, 2017

Indian Prime Minister Narendra Modi has declared that his nation is “open for business,” but some U.S. industry leaders remain troubled by India’s policy toward intellectual property rights and question whether the new leader, making his first visit to Washington this week, will follow through on his promise to address the problem. Mr. Modi, who...

www.washingtontimes.com

 •  February 14, 2017

A powerful House committee approved a bill Tuesday to repeal Obamacare’s medical device tax, a provision that’s been criticized by members of both parties as a misguided way to pay for the health overhaul. The Ways and Means Committee voted 25-14 to repeal the 2.3-percent excise on sales of pacemakers, artificial joints and other devices, with Rep....

www.washingtontimes.com

 •  February 14, 2017

BEIJING (AP) - China must exert stronger oversight over vaccines sold on the private market in the wake of a developing scandal involving expired or improperly stored vaccines, the World Health Organization said Tuesday. Dr. Lance Rodewald of WHO China’s immunization program told reporters that the ongoing investigation into the “troubling” scandal...